Cholesterol in the Viral Membrane is a Molecular Switch Governing HIV‐1 Env Clustering
暂无分享,去创建一个
J. A. Nieto-Garai | H. Kräusslich | Maier Lorizate | F. Contreras | J. Chojnacki | J. Casas | G. Fabriàs | Aroa Arboleya | Sara Otaegi
[1] K. Salaita,et al. Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters. , 2020, ACS nano.
[2] J. Chou,et al. Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein , 2020, Nature Communications.
[3] Philip D. Plowright. Front , 2019, 2020 Fourth World Conference on Smart Trends in Systems, Security and Sustainability (WorldS4).
[4] J. Houtman,et al. The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization , 2019, The Journal of Biological Chemistry.
[5] S. V. van Engelenburg,et al. Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation , 2019, Proceedings of the National Academy of Sciences.
[6] H. Kräusslich,et al. Quantification of phosphoinositides reveals strong enrichment of PIP2 in HIV-1 compared to producer cell membranes , 2019, Scientific Reports.
[7] E. Freed,et al. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions , 2019, Journal of Virology.
[8] M. Veit,et al. Cholesterol Binding to the Transmembrane Region of a Group 2 Hemagglutinin (HA) of Influenza Virus Is Essential for Virus Replication, Affecting both Virus Assembly and HA Fusion Activity , 2019, Journal of Virology.
[9] Marc C. Johnson,et al. A lipid-based partitioning mechanism for selective incorporation of proteins into membranes of HIV particles , 2019, Nature Cell Biology.
[10] J. A. Nieto-Garai,et al. Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure , 2018, Front. Immunol..
[11] D. Weissman,et al. Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization , 2018, Virology.
[12] R. E. Murphy,et al. Solution Structure and Membrane Interaction of the Cytoplasmic Tail of HIV-1 gp41 Protein. , 2017, Structure.
[13] J. Enderlein,et al. Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state , 2017, Nature Communications.
[14] F. Dumas,et al. Lipids in infectious diseases - The case of AIDS and tuberculosis. , 2017, Biochimica et biophysica acta. Biomembranes.
[15] R. Wyatt,et al. Dense Array of Spikes on HIV-1 Virion Particles , 2017, Journal of Virology.
[16] R. Böckmann,et al. Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function , 2016, Front. Physiol..
[17] F. Wieland,et al. Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol , 2015, Nature Communications.
[18] Benjamin K. Chen,et al. HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail , 2015, Journal of Virology.
[19] A. Trkola,et al. Different Infectivity of HIV-1 Strains Is Linked to Number of Envelope Trimers Required for Entry , 2015, PLoS pathogens.
[20] E. Freed,et al. The role of matrix in HIV-1 envelope glycoprotein incorporation. , 2014, Trends in microbiology.
[21] Charles R Sanders,et al. Cholesterol as a co‐solvent and a ligand for membrane proteins , 2014, Protein science : a publication of the Protein Society.
[22] G. Jennings,et al. Evaluation of steroidal amines as lipid raft modulators and potential anti-influenza agents. , 2013, Bioorganic & medicinal chemistry letters.
[23] Brent R. Martin. Nonradioactive Analysis of Dynamic Protein Palmitoylation , 2013, Current protocols in protein science.
[24] H. Schaal,et al. Detection and initial characterization of protein entities consisting of the HIV glycoprotein cytoplasmic C-terminal domain alone. , 2013, Virology.
[25] Hans-Georg Kräusslich,et al. Comparative lipidomics analysis of HIV‐1 particles and their producer cell membrane in different cell lines , 2013, Cellular microbiology.
[26] Thorsten Staudt,et al. Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy , 2012, Science.
[27] Baoshan Zhang,et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.
[28] W. Sundquist,et al. HIV-1 assembly, budding, and maturation. , 2012, Cold Spring Harbor perspectives in medicine.
[29] E. Freed,et al. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. , 2011, Journal of molecular biology.
[30] D. Tyrrell,et al. Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses , 2010, Proceedings of the National Academy of Sciences.
[31] Robert Damoiseaux,et al. A broad-spectrum antiviral targeting entry of enveloped viruses , 2010, Proceedings of the National Academy of Sciences.
[32] Polung Yang,et al. The Cytoplasmic Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 Harbors Lipid Raft Association Determinants , 2009, Journal of Virology.
[33] F. Wieland,et al. Probing HIV-1 Membrane Liquid Order by Laurdan Staining Reveals Producer Cell-dependent Differences* , 2009, The Journal of Biological Chemistry.
[34] Annick Thomas,et al. Large changes in the CRAC segment of gp41 of HIV do not destroy fusion activity if the segment interacts with cholesterol. , 2008, Biochemistry.
[35] S. S. Chen,et al. Identification of the LWYIK Motif Located in the Human Immunodeficiency Virus Type 1 Transmembrane gp41 Protein as a Distinct Determinant for Viral Infection , 2008, Journal of Virology.
[36] P. Uchil,et al. Retroviruses Human Immunodeficiency Virus and Murine Leukemia Virus Are Enriched in Phosphoinositides , 2008, Journal of Virology.
[37] K. Nagashima,et al. Inhibition of Human Immunodeficiency Virus Type 1 Assembly and Release by the Cholesterol-Binding Compound Amphotericin B Methyl Ester: Evidence for Vpu Dependence , 2008, Journal of Virology.
[38] T. Veenstra,et al. Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. , 2008, Biochemistry.
[39] E. Freed,et al. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease , 2007, Proceedings of the National Academy of Sciences.
[40] R. Ptak,et al. Inhibition of HIV-1 Replication by Amphotericin B Methyl Ester , 2006, Journal of Biological Chemistry.
[41] J. Lifson,et al. Distribution and three-dimensional structure of AIDS virus envelope spikes , 2006, Nature.
[42] J. Bhattacharya,et al. Gag Regulates Association of Human Immunodeficiency Virus Type 1 Envelope with Detergent-Resistant Membranes , 2006, Journal of Virology.
[43] Annick Thomas,et al. Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. , 2006, Biochemistry.
[44] Hans-Georg Kräusslich,et al. The HIV lipidome: a raft with an unusual composition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[45] Oliver T. Fackler,et al. Construction and Characterization of a Fluorescently Labeled Infectious Human Immunodeficiency Virus Type 1 Derivative , 2004, Journal of Virology.
[46] D. Graham,et al. Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. , 2003, AIDS research and human retroviruses.
[47] C. Genin,et al. Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. , 2002, Biochimica et biophysica acta.
[48] J. Mak,et al. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity , 2002, AIDS.
[49] G. Lucero,et al. A dominant block to HIV-1 replication at reverse transcription in simian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[50] W. Greene,et al. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.
[51] S. Nir,et al. Sphingomyelin and Cholesterol Promote HIV-1 gp41 Pretransmembrane Sequence Surface Aggregation and Membrane Restructuring* , 2002, The Journal of Biological Chemistry.
[52] J. Hoxie,et al. Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus , 2002, Journal of Virology.
[53] H. Katinger,et al. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. , 2001, AIDS research and human retroviruses.
[54] Dzung H. Nguyen,et al. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. , 2001, AIDS research and human retroviruses.
[55] P. S. Kim,et al. Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] Kai Simons,et al. Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.
[57] C. Martínez-A,et al. Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection , 2000, EMBO reports.
[58] H. Kräusslich,et al. Biochemical and Structural Analysis of Isolated Mature Cores of Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.
[59] E. Freed,et al. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Engelman,et al. Caveolins, Liquid-Ordered Domains, and Signal Transduction , 1999, Molecular and Cellular Biology.
[61] Xiao-Fang Yu,et al. Highly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions , 1999, Journal of Virology.
[62] Y. Shai,et al. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. , 1997, Biochemistry.
[63] R. Compans,et al. The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[64] J. Zimmerberg,et al. The hemifusion intermediate and its conversion to complete fusion: regulation by membrane composition. , 1995, Biophysical journal.
[65] C. Rinaldo,et al. Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. , 1993, Virology.
[66] F. Jensen,et al. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[67] R. Compans,et al. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. , 1992, The Journal of biological chemistry.
[68] Deborah A. Brown,et al. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.
[69] F. Jensen,et al. Lipid composition and fluidity of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[70] Y. Barenholz,et al. Effect of cholesterol concentration on organization of viral and vesicle membranes. Probed by accessibility to cholesterol oxidase. , 1980, The Journal of biological chemistry.
[71] F. Fahrenholz,et al. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles , 1999, Nature Cell Biology.
[72] J. Moore,et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor , 1998, Nature Medicine.